Annotate as NK cells. they are CD3 negative but expressing NCAM1, KLRD1. Nature Immunology volume 25, pages 1474–1488 (2024)
Annotate as NK cells. they are CD3 negative but expressing NCAM1, KLRD1. Nature Immunology volume 25, pages 1474–1488 (2024)
they are the same subset, expressing IL-23R and TNFR25. Actually "ILC2" express more IL22 a marker of ILC3. Merge both into ILC3.
they are the same subset, expressing IL-23R and TNFR25. Actually "ILC2" express more IL22 a marker of ILC3. Merge both into ILC3.
Delete. This cluster is noise. Has no B cell marker. Markers include secretory epithelial markers ZG16, CLCA1, MUC2.
This is a heterogeneous cluster, containing at least 3 different subsets. Only 1 of them has the canonical CXCL13, IL21 Tfh. A second subset not expressing these genes but with expression of CXCR5 and CCR6. The third subset has no markers of Tfh, and expresses several heat shock gene markers and CCL20. I would re-annotate this last cluster (number 3_3 in Leiden L2) as Heat shock T cells.
Split into CD8+ naive (CD8A, CCR7, SELL) and the other cluster (negative for CCR7 and SELL) which appears to be jejunal (and accordingly expressing CCR9).
Agree with splitting into IKZF2+ (also expressing CCR8 RTKN2) with a highly suppressive phenotype, and IKZF2- (also IL10+).
There is a mixture of naive T cells (left cluster) expressing CCR7, LSEL, and not naive ( cluster on the right lacks these two canonical markers of naive lymphocytes) expressing cytokines (IFNG, TNF, tnfsf13B, tnfrsf25, il2, cd40lg etc). This will fit with an effector phenotype.
Annotate as NK cells. they are CD3 negative but expressing NCAM1, KLRD1. Nature Immunology volume 25, pages 1474–1488 (2024)
they are the same subset, expressing IL-23R and TNFR25. Actually "ILC2" express more IL22 a marker of ILC3. Merge both into ILC3.
they are the same subset, expressing IL-23R and TNFR25. Actually "ILC2" express more IL22 a marker of ILC3. Merge both into ILC3.
Delete. This cluster is noise. Has no B cell marker. Markers include secretory epithelial markers ZG16, CLCA1, MUC2.
This is a heterogeneous cluster, containing at least 3 different subsets. Only 1 of them has the canonical CXCL13, IL21 Tfh. A second subset not expressing these genes but with expression of CXCR5 and CCR6. The third subset has no markers of Tfh, and expresses several heat shock gene markers and CCL20. I would re-annotate this last cluster (number 3_3 in Leiden L2) as Heat shock T cells.
Split into CD8+ naive (CD8A, CCR7, SELL) and the other cluster (negative for CCR7 and SELL) which appears to be jejunal (and accordingly expressing CCR9).
Agree with splitting into IKZF2+ (also expressing CCR8 RTKN2) with a highly suppressive phenotype, and IKZF2- (also IL10+).
There is a mixture of naive T cells (left cluster) expressing CCR7, LSEL, and not naive ( cluster on the right lacks these two canonical markers of naive lymphocytes) expressing cytokines (IFNG, TNF, tnfsf13B, tnfrsf25, il2, cd40lg etc). This will fit with an effector phenotype.
Agree with the overall annotation, as PROX1, FLT4 as "lymphatic endothelial cells (LEC)". Although the cell number is low there is heterogeneity in some canonical markers that would suggest the presence of LEC subsets within the cluster annotated now as "Vascular Endothelial Lymphatic". For instance, not all express LYVE1 or CCL21. Indeed, cells lacking expression of these two markers express ACKR4 (Leiden lineage L2 cluster 13_3) could be annotated as Ceiling subcapsular sinus LECs (https://doi.org/10.1016/j.immuni.2019.06.027) . Also clusters 13_0 and 13_1 do express LYVE1, CCL21 as well as CLEC4M marker of medullary sinus LECs (https://doi.org/10.1016/j.immuni.2019.06.027).
This cluster contains a mix of cells. One of the markers mentioned in the metadata as specific is PLVAP (not expressed by half of the cells in this cluster). I would suggest selectin leiden L1 cluster 14 (as the arterial endothelium using GJA5 and SEMA3G as markers). Cluster 14, however, lacks PLVAP (highly expressed in clusters 3 and 17) which I would annotate as capilary (based on PLVAP expression).
They expressed well-described canonical markers of lamina propria fibs.
this cluster also expressed NRG1, demonstrated to be crypt top (validated in https://doi.org/10.1038/s41467-023-40156-6 by ISH).
this cluster also expressed NRG1, demonstrated to be crypt top (validated in https://doi.org/10.1038/s41467-023-40156-6 by ISH).
Markers of subepithelial F3, SOX6 wnt5b expressed by this cluster.
This cluster shows expression of adhesion molecules MADCAM, SELEP and SELE normally described in inflammed endothelium but also described in venular endothelium. It also expresses another marker of venular endothelium lrg1.
Delete
Delete.
Agree with the overall annotation, as PROX1, FLT4 as "lymphatic endothelial cells (LEC)". Although the cell number is low there is heterogeneity in some canonical markers that would suggest the presence of LEC subsets within the cluster annotated now as "Vascular Endothelial Lymphatic". For instance, not all express LYVE1 or CCL21. Indeed, cells lacking expression of these two markers express ACKR4 (Leiden lineage L2 cluster 13_3) could be annotated as Ceiling subcapsular sinus LECs (https://doi.org/10.1016/j.immuni.2019.06.027) . Also clusters 13_0 and 13_1 do express LYVE1, CCL21 as well as CLEC4M marker of medullary sinus LECs (https://doi.org/10.1016/j.immuni.2019.06.027).
This cluster contains a mix of cells. One of the markers mentioned in the metadata as specific is PLVAP (not expressed by half of the cells in this cluster). I would suggest selectin leiden L1 cluster 14 (as the arterial endothelium using GJA5 and SEMA3G as markers). Cluster 14, however, lacks PLVAP (highly expressed in clusters 3 and 17) which I would annotate as capilary (based on PLVAP expression).
They expressed well-described canonical markers of lamina propria fibs.
this cluster also expressed NRG1, demonstrated to be crypt top (validated in https://doi.org/10.1038/s41467-023-40156-6 by ISH).
this cluster also expressed NRG1, demonstrated to be crypt top (validated in https://doi.org/10.1038/s41467-023-40156-6 by ISH).
Markers of subepithelial F3, SOX6 wnt5b expressed by this cluster.
This cluster shows expression of adhesion molecules MADCAM, SELEP and SELE normally described in inflammed endothelium but also described in venular endothelium. It also expresses another marker of venular endothelium lrg1.
Delete
Delete.
Change name to Mast Cells.
"Tissue resident" is too broad and it should include also: M0, FOLR2, LYVE1, PLA2G2D macrophages. M0 (https://doi.org/10.1038/s41467-023-40156-6) are resident macs (expressing all canonical mac markers C1QA, C1QB, C1QC, SELENOP, RNASEL1, CD163, etc, but lacking the "M2" markers FOLR2, CD209, CD163L1, MAF, STAB1, etc). I would suggest merging clusters 7 and 6 with cluster 8 Leiden L1 (all FOLR2 macrophages), cluster 1 as M0, and cluster 14 as PLA2G2D macrophages. the latter not formally described yet in human. We have 2 oral presentations at ECCO and a MS in preparation describing this as a distinct population of macrophages detected in isolated lymphoid structures. They have been described in mice previously (
https://doi.org/10.1084/jem.20121887).
M2 is outdated. I would suggest FOLR2 as a better marker for resident macrophages. I would divide into the lyve1+ (cluster 9 in Leiden L1) and lyve1- folr2+ (cluster 8 in Leiden L1). Lyve1+ are considered perivascular. Also, C1Q genes, as well as SELENOP, etc are general markers of macrophages (not of the "M2").
Agree with this being FDCs, but also that they are not of myeloid origin (and should be merged with stromal compartment).
Change name to Mast Cells.
"Tissue resident" is too broad and it should include also: M0, FOLR2, LYVE1, PLA2G2D macrophages. M0 (https://doi.org/10.1038/s41467-023-40156-6) are resident macs (expressing all canonical mac markers C1QA, C1QB, C1QC, SELENOP, RNASEL1, CD163, etc, but lacking the "M2" markers FOLR2, CD209, CD163L1, MAF, STAB1, etc). I would suggest merging clusters 7 and 6 with cluster 8 Leiden L1 (all FOLR2 macrophages), cluster 1 as M0, and cluster 14 as PLA2G2D macrophages. the latter not formally described yet in human. We have 2 oral presentations at ECCO and a MS in preparation describing this as a distinct population of macrophages detected in isolated lymphoid structures. They have been described in mice previously (
https://doi.org/10.1084/jem.20121887).
M2 is outdated. I would suggest FOLR2 as a better marker for resident macrophages. I would divide into the lyve1+ (cluster 9 in Leiden L1) and lyve1- folr2+ (cluster 8 in Leiden L1). Lyve1+ are considered perivascular. Also, C1Q genes, as well as SELENOP, etc are general markers of macrophages (not of the "M2").
Agree with this being FDCs, but also that they are not of myeloid origin (and should be merged with stromal compartment).